Article Text

PDF

Chronic disease
P2-161 Increased melanoma risk among melanoma patients
  1. L Liu1,
  2. R van der Leest3,
  3. T Nijsten3,
  4. J W Coebergh1,2,
  5. E de Vries1,3
  1. 1Deparment of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
  2. 2Comprehensive Cancer Center South (IKZ), Eindhoven, The Netherlands
  3. 3Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands

Abstract

Background Study on risk of subsequent melanoma among melanoma patients is scarce.

Objective To investigate melanoma risk in melanoma patients.

Material and Methods Netherlands Cancer Registry incidence data (1989–2008) were employed. Patients (N=57 817) diagnosed melanoma in this period were followed. Follow-up censored at second melanoma, death or end of study. Standardised incidence ratio (SIR) was used expressing RR compared to the general population. Sex-and follow-up-specific SIR were computed under for both first and second in situ and invasive melanomas. Cox regression model which contains age at diagnosis, sex, Breslow thickness, and follow-up periods was constructed to estimate relative excessive risk melanoma risk.

Results During a median of 3 yrs of follow-up time, 1985 patients diagnosed for a second melanoma. After both in situ and invasive melanoma, inflated risk for a second melanoma was observed: after a first in situ melanoma, the risk to develop a subsequent melanoma was 16.3 (SIR), 95% CI 14.7 to 17.9. Following an invasive melanoma, risk was 13.3 (SIR), 95% CI 12.6 to 14.1. Elevated risks were observed in all follow-up periods (0–1 yr, 2–5 yr, 6–10 yrs, 10–15 yrs, 16–20 yrs) in both sexes. Age at diagnosis, sex, Breslow thickness, were shown to explain the excess risk observed in those follow-up periods.

Discussion and Conclusion Based on the persistently high risk of melanoma among melanoma patients, a long-term follow-up schedule is needed for both patients and clinicians.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.